Marnie owns more than 60% of Anaerzia’s outstanding shares and has been appointed Chairman of the Board of Directors.
Burlington, Ontario, July 10, 2024–(BUSINESS WIRE)–ANAELZIA CO., LTD.(“Apnea” or “companyCanada On Demand Limited (TSX: ANRG), a Canadian renewable energy company and global leader in renewable fuels, has announced that it has completed the closing of the third tranche of its previously announced C$40.8 million equity investment (the “Strategic InvestmentsMarny Investissement SAMarnie(“Marny Holdco”), a wholly owned subsidiary of Marny Holdco Inc. (“Marnie Holdko) today completed the issuance of 36,750,000 units of the Company’s common stock (the “unit” ) has gross proceeds of C$14.7 million. Each Unit represents one subordinate voting share of the Company (each a “Subordinate Voting Shares) and 1/5 of the Company’s subordinate voting stock purchase rights (respectively “warrantEach warrant entitles the holder to purchase one additional subordinate voting share at an exercise price of C$0.80 by February 2, 2027. In total, 102 million units were issued to Marny Holdco pursuant to the strategic investment.
The closing of the third tranche of this strategic investment follows the resumption of trading yesterday on the Toronto Stock Exchange (“TSX(hereinafter referred to as “Subordinate Voting Shares”)
Upon the closing of the third tranche of the strategic investment, Dr. Andrew Benedek has agreed to convert the last third of all of his multiple voting shares in the Company into subordinate voting shares on a one-for-one basis pursuant to the AnaGear Definitive Documents. Upon the closing of the third tranche of the strategic investment, assuming full exercise of the warrants, Dr. Andrew Benedek now holds approximately 19.5% of the voting power attached to the subordinate voting shares (on a non-diluted basis) and approximately 17.4% of the voting power attached to the subordinate voting shares (on a partially diluted basis). Marny Holdco will own and control approximately 60.9% of the voting power attached to the subordinate voting shares (on a non-diluted basis) and approximately 65.2% of the voting power attached to the subordinate voting shares (on a partially diluted basis), assuming full exercise of the warrants.
In connection with the Strategic Investment, Anaergia has undertaken to the TSX to reclassify the Subordinate Voting Shares as “Common Shares” and remove the Multiple Voting Shares from Anaergia’s authorized capital within 60 days following the closing of the third tranche of the Strategic Investment. Pursuant to the Voting and Support Agreement, Dr. Andrew Benedek has agreed to vote in favour of the reclassification.
Following the completion of the third tranche of the strategic investment, Ohad Epschtein, the beneficial owner and nominee of Marny Holdco, has been appointed to the company’s Board of Directors. As Marny has controlling interest in Anaergia, Mr. Epschtein will assume the role of Chairman of the Board, a role previously held by Dr. Andrew Benedek, who continues to serve as a director of the company.
“I am thrilled that Ohad and his team share my enthusiasm for Anaerzia and are committed to growing the company and realizing its full potential,” said Andrew Benedek. “I have no doubt that Ohad is the right person to lead the board going forward,” Dr. Benedek added.
“Andrew Benedek founded Anaerzia and, under his direction, has grown the company into one of the technology leaders in the global renewable biogas sector,” said Ohad Epshteyn. “For this reason, we are fascinated by the company’s potential and genuinely look forward to being part of Anaerzia’s future journey,” Epshteyn added.
About Marnie
Marny is a Luxembourg holding company investing in investment properties around the world. Marny uses the latest technology and materials in its build-own-operate projects and partners with global market leaders to enhance the value of its investments.
About Anergia
Anergy was created to eliminate a major source of greenhouse gases (“Greenhouse gasesBy cost-effectively converting organic waste into renewable natural gas (“Random Number GeneratorAnaergia uses proprietary technologies to reuse waste, fertilizer and water. With a proven track record of delivering innovative projects, Anaergia is uniquely positioned to provide solutions to today’s most pressing resource recovery challenges with a broad, proven technology portfolio and multiple project delivery methodologies. Anaergia is one of the few companies in the world with a unique portfolio of end-to-end solutions that integrate solid waste processing and wastewater treatment with organic matter recovery, highly efficient anaerobic digestion, RNG production, and fertilizer and water recovery from organic residues. The combination of these technologies enhances the production of carbon-negative biogas, clean water and natural fertilizer, minimizes the footprint, and reduces waste and wastewater treatment costs and GHG emissions.
For more information, please visit www.anaergia.com.
Forward-Looking Statements
This news release contains forward-looking information within the meaning of applicable securities laws, which reflect Anaergia’s current expectations regarding future events, including, but not limited to: The Company has prepared forward-looking information carefully to facilitate the optimization of the Company’s growth and potential. The forward-looking information is based on a number of assumptions, including, but not limited to, the optimization of the Company’s growth capabilities and potential. The Company is subject to a number of risks and uncertainties, many of which are beyond the Company’s control. Such risks and uncertainties include, but are not limited to, the factors discussed under “Risk Factors” in the Company’s Annual Information Form for the fiscal year ended December 31, 2023 and “Risks and Uncertainties” in the Company’s most recent management’s discussion and analysis. Actual results may differ materially from those projected herein. Anaergia undertakes no obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws. Additional information regarding these and other factors that may affect Anaergia’s operations or financial results is included in Anaergia’s reports filed with Canadian regulatory authorities.
This news release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state of the United States or other jurisdiction in which such offer, solicitation or sale would be unlawful.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240710056325/en/
contact address
For media and investor relations inquiries, please contact IR@Anaergia.com
